Treatment of Androgenetic Alopecia in Females, 12 Beam

2014-08-27 03:17:50 | BioPortfolio


The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.


This is a randomized double-blind, sham controlled clinical study, evaluating changes in terminal hair count in the evaluation zone having evidence of androgenetic alopecia (miniaturized hair).

The trial with 60 female subjects, who have been diagnosed with androgenetic alopecia, who are between 25 and 60 years of age, have Fitzpatrick Skin Types I-IV, with classifications of Ludwig I-4, II-1, II-2, or frontal, have active hair loss within the last 12 months.

Subjects will use the device on three non-concurring days a week as directed per device for 26 weeks duration.

Initial efficacy endpoint for each subject will be assessed at visit 4 (week 16).

Safety analysis will be assessed based on the reports of adverse events during study.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Androgenetic Alopecia


HairMax LaserComb 2009 model 12 beam, Sham Device


University of Miami Miller School of Medicine - Dermatology
United States




Lexington International, LLC

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:17:50-0400

Clinical Trials [1455 Associated Clinical Trials listed on BioPortfolio]

Treatment of Androgenetic Alopecia in Females, 9 Beam

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 beam model in promoting hair growth in females diagnosed with androgenetic alopecia when treatment is ...

Treatment of Androgenetic Alopecia in Males

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in men diagnosed with androgenetic alopecia when treatment is appl...

Treatment of Androgenic Alopecia in Males

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 & 12 Beam models in promoting hair growth in men diagnosed with androgenetic alopecia when treatment i...

Hairmax Lasercomb For The Treatment Of Androgenetic Alopecia In Females

HairMax 12 2009-F-02 is a double blind study to evaluate the treatment of androgenetic alopecia.

HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis

The purpose of this study is to test whether the stimulation of vascularization and cellular metabolism on the scalp by use of the HairMax LaserComb will produce improvement in the conditi...

PubMed Articles [12746 Associated PubMed Articles listed on BioPortfolio]

Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial.

Previous studies have reported the benefits of low-level/light laser therapy (LLLT) for the promotion of hair regrowth. However, the effectiveness of LLLT for the treatment of androgenetic alopecia (A...

The tendency towards the development of psychosexual disorders in androgenetic alopecia according to the different stages of hair loss: a cross-sectional study.

Androgenetic alopecia is a common dermatological condition affecting both genders.

Acute Effects of Device-Guided Slow Breathing on Sympathetic Nerve Activity and Baroreflex Sensitivity in Posttraumatic Stress Disorder.

Posttraumatic stress disorder (PTSD) patients have elevated sympathetic nervous system (SNS) reactivity and impaired sympathetic and cardiovagal baroreflex sensitivity (BRS). Device-guided slow breath...

Modified device for fluid percussion injury in rodents.

Fluid percussion (FP) injury model is a popular animal model of traumatic brain injury (TBI), but still there are some issues need to be addressed. To increase the validity and reliability of this tec...

Designing optical circuits using plasmonic beam splitters.

Plasmonic optical circuits hold great promise in reducing device footprints by orders of magnitude and enabling high device complexity. The decomposition of an arbitrary linear transformation using un...

Medical and Biotech [MESH] Definitions

The science and application of a double-beam transmission interference microscope in which the illuminating light beam is split into two paths. One beam passes through the specimen while the other beam reflects off a reference mirror before joining and interfering with the other. The observed optical path difference between the two beams can be measured and used to discriminate minute differences in thickness and refraction of non-stained transparent specimens, such as living cells in culture.

A novel composition, device, or process, independently conceived de novo or derived from a pre-existing model.

Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.

Statistical formulations or analyses which, when applied to data and found to fit the data, are then used to verify the assumptions and parameters used in the analysis. Examples of statistical models are the linear model, binomial model, polynomial model, two-parameter model, etc.

Removal of a MEDICAL DEVICE from the market due to the identification of an intrinsic property of the device that results in a serious risk to public health.

More From BioPortfolio on "Treatment of Androgenetic Alopecia in Females, 12 Beam"

Quick Search


Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Searches Linking to this Trial